4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid,3,3-dimethyl-6-[[[[[[[3-(methylsulfonyl)-2-oxo-1-imidazolidinyl]carbonyl]amino]carbonyl]amino]phenylacetyl]amino]-7-oxo-, monosodium salt,[2S-[2a,5a,6b(S*)]]-
| Title | Journal |
|---|---|
| Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps). | PLoS computational biology 20111201 |
| A predictive ligand-based Bayesian model for human drug-induced liver injury. | Drug metabolism and disposition: the biological fate of chemicals 20101201 |
| Effects of prophylactic antibiotic therapy with mezlocillin plus sulbactam on the incidence and height of fever after severe acute ischemic stroke: the Mannheim infection in stroke study (MISS). | Stroke 20080401 |
| Antibiotic therapy for preterm premature rupture of membranes - results of a multicenter study. | Journal of perinatal medicine 20060101 |
| Clinical determinants for the recovery of fungal and mezlocillin-resistant pathogens from bile specimens. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20020401 |
| [Analysis of prophylactic antibiotics for cesarean section]. | Zhonghua fu chan ke za zhi 20020101 |
| Efficacy of oral ofloxacin for single-dose perioperative prophylaxis in general surgery--a controlled randomized clinical study. | Langenbeck's archives of surgery 20011101 |
| Pharmacokinetic basis for oral perioperative prophylaxis with ofloxacin in general surgery. | Infection 20010801 |
| In vitro activity of mezlocillin, meropenem, aztreonam, vancomycin, teicoplanin, ribostamycin and fusidic acid against Borrelia burgdorferi. | International journal of antimicrobial agents 20010301 |
| Treatment of accidental high dose intraventricular mezlocillin application by cerebrospinal fluid exchange. | Journal of neurology, neurosurgery, and psychiatry 19980301 |
| A prospective randomized trial of ceftazidime versus netilmicin plus mezlocillin in the empirical therapy of presumed sepsis in cirrhotic patients. | Hepatology (Baltimore, Md.) 19970401 |
| Pharmacokinetics of mezlocillin and sulbactam under continuous veno-venous hemodialysis (CVVHD) in intensive care patients with acute renal failure. | European journal of clinical pharmacology 19970101 |
| Severe cholestatic jaundice caused by mezlocillin. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 19920701 |
| A controlled study of the nephrotoxicity of mezlocillin and gentamicin plus ampicillin in the neonate. | The Journal of pediatrics 19871201 |
| Acute interstitial nephritis associated with mezlocillin, nafcillin, and gentamicin treatment for Pseudomonas infection. | Archives of internal medicine 19850701 |